期刊文献+

膀胱内灌注辣椒辣素类似物治疗女性膀胱过度活动症疗效分析 被引量:1

The rapeutic Analysis of Intravesical Instillation Resiniferatoxin for the Treatment with Overactive Bladder in Female
下载PDF
导出
摘要 目的:探讨膀胱灌注辣椒辣素类似物(RTX)治疗女性膀胱过度活动症(OAB)的临床效果。方法:34例OAB患者随机分为实验组与对照组,实验组19例用0.5%利多卡因溶液40mL从导尿管注入膀胱,保留3min后全部排出,予以膀胱灌注辣椒辣素类似物(RTX)治疗,对照组15例用1:5000呋喃西林(安慰剂)替代RTX,方法同实验组。观察两组用药前、用药后1个月、3个月、6个月的临床症状(每日排尿次数、尿急程度)。结果:治疗前与治疗后1个月、3个月、6个月的临床症状比较,实验组差异有显著意义(P<0.01)。10/19例(52.6%)有轻度尿道刺激症状或膀胱区不适,均可耐受。对照组无差异(P<0.05)。结论:RTX单剂量膀胱灌注能安全有效地改善女性OAB临床症状。 Objective To explore the clinical outcomes of intravesical instillation resiniferatoxin (RTX) for the treatment of patients with overactive bladder in female. Methods 34 cases with OAB were randomly divided into test (19 cases) and control (15 cases) groups. The patients in test group were treated by intravesical instillation with 40 mL of 0.5% lidocain retained within the bladder for 3 minutes at first and with 100 mL of 100 nmol/L RTX retained within the bladder for 30 minutes late. The patients in control group were treated by the same method, however, the furacilin solution (placebo) at a dilution 1:5000 was used instead of 100 nmol/L RTX.The efficacy (daily voiding frequency, urgent uresis) of the 2 groups were evaluated before, 1 month, 3 months and 6 months after treatment. Results Before treatment in test group compared with test group at 1 month, 3 months and 6 months after treatment was significant ( P 〈 0.01), and control group was not significant (P 〉 0.05). 14/19 patients (52.6%)had slightly stimulating symptom in the urethra or bladder, and were otherwise generally well tolerated. Conclusion Single administration of RTX is safe and effective in patients with OAB in female.
出处 《深圳中西医结合杂志》 2009年第2期101-103,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 深圳市科技计划资助项目(200803041)
关键词 膀胱过度活动症 辣椒辣素类似物 随机对照试验 Overactive bladder Resiniferatoxin Randomized controlled trial
  • 相关文献

参考文献10

  • 1Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Subcommittee of the International Continence Society [J]. Neurourol Urodyn, 2002, 21(2): 167
  • 2Wein A J, Rovner E S. Definition and epidemiology of overactive ladder[J].Urology, 2002, 60 (5 suppl 1):7
  • 3Debmyne F M, Heesakkers J E Clinical and Socioeconomic relevance of overactive bladde[J]. Urology, 2004, 63 (3 Suppl1):42
  • 4Milsom I, Stewart W, Thuroff J. The prevalence of overactive bladder[J]. Am J Manag Care, 2000, 6(11 Suppl1): S565
  • 5Temml C, Heidler S, Ponhoker A, et al. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition [J]. Eur Urol, 2005, 48:622-627
  • 6何梓铭.膀胱过度活动症(OAB)治疗近况[J].实用医院临床杂志,2005,2(1):24-25. 被引量:8
  • 7Yoshimura N, De Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation [J]. J Neurosci, 1999, 19 (11):4644-4653
  • 8Yoshimura N. Bladder afferent pathway and spinal cord injury : possible mechanisms inducing hyperreflexia of the urinary bladder[J].Prog Neurobiol, 1999,57 (6):583-606
  • 9Lazzeri M, Vannucchi MG. Zardo C, et al. Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder [J]. Eur Urol, 2004, 46:792-798
  • 10关志忱,周锦棠.膀胱过度活动症膀胱内药物治疗[J].中华泌尿外科杂志,2007,28(1):68-70. 被引量:12

二级参考文献22

  • 1关志忱,李贤新.辣椒辣素灌注对大鼠膀胱组织的影响[J].中华泌尿外科杂志,2006,27(3):181-183. 被引量:3
  • 2Kuo HC. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology, 2005,66:94-98.
  • 3Giannantoni A, Mearini E, Di Stasi SM, et al. New therapeutic options for refractory neurogenic detrusor overactivlty. Minerva Urol Nefrol,2004,56:79-87.
  • 4Weese DL, Roskamp DA, Leach GE,et al. Intravesical oxybutynin chloride: experience with 42 patients.Urology, 1993,41:527-530.
  • 5De Waehter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol,2003,169:1892-1895.
  • 6Stewart WF, Van Rooyen JB, et al.Prevalence and burden of overactive bladder in the United States. World J Uroh 2003,20: 327-336.
  • 7Temml C, Heldler S, Ponholzer A, et al. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.Eur Urol, 2005, 48:622-627.
  • 8Homma Y, Yamaguehi O, Hayashi K,et al. An epidemiologieal survey of overactive bladder symptoms in Japan.BJU Int, 2005,96:1314-1318.
  • 9Lazzeri M, Vannueehi MG, Zardo C,et al. Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder. Eur Urol, 2004,46 :792-798.
  • 10de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: a double blind placebocontrolled study in 20 patients with spinal cord lesions. Neurourol Urodyn, 1998,17:513-523.

共引文献18

同被引文献30

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部